Compare ANX to:
After Hours: 0.099 N/A (N/A) 8:27am ET
| Last Trade: | 0.101 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 0.099 |
| Open: | 0.10 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 1.20 |
| Day's Range: | 0.09 - 0.104 |
|---|---|
| 52wk Range: | 0.07 - 0.25 |
| Volume: | 1,801,704 |
| Avg Vol (3m): | 2,657,860 |
| Market Cap: | 15.54M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.175 |
| Div & Yield: | N/A (N/A) |
| Wed, Nov 25 | [video] $5 Gold Stocksat TheStreet.com |
| Tue, Nov 17 | ADVENTRX PHARMACEUTICALS INC FinancialsEDGAR Online Financials |
| Tue, Nov 10 | ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online |
| Tue, Nov 10 | ADVENTRX Pharmaceuticals Reports Third Quarter Financial ResultsPR Newswire |
| Fri, Oct 23 | Trading Review for Adventrx Pharmaceuticals Inc. Issued by Beacon EquityGlobeNewswire |
| Thu, Oct 22 | ADVENTRX Pharmaceuticals to Present at the BIO Investor Forum on October 29PR Newswire |
| Tue, Oct 20 | Midday Movers: Pump Up the Volumeat TheStreet.com |
| Tue, Oct 20 | CEO Interview: ADVENTRX Pharmaceuticals, Inc. - Brian M. CulleyWall Street Transcript |
| Tue, Oct 20 | ADVENTRX Provides Business Update Following Recent Financing ActivityPR Newswire |
| Mon, Oct 19 | ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.